We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

By LabMedica International staff writers
Posted on 22 Sep 2025

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. More...

Standard care can be hindered by delays in identifying the type of transfusion needed to stop bleeding. Now, a real-time blood-monitoring approach has shown potential to provide rapid, detailed insights into clotting, bringing hospitals closer to faster and more effective emergency care.

Researchers from the Keck School of Medicine of USC (Los Angeles, CA, USA) conducted a comprehensive review of viscoelastic testing (VET), a minimally invasive diagnostic technology. VET detects how well blood is clotting and identifies which blood components—such as plasma, platelets or whole blood—are most effective for treating hemorrhage. Already approved by the U.S. FDA for use in surgeries and trauma, the test is not yet standard in maternity care.

The review analyzed findings from 156 studies and included interviews with patients, providers and policymakers. Evidence suggests VET can improve management of postpartum hemorrhage, but only two randomized controlled trials were identified, highlighting the need for stronger data. The review, published in the International Journal of Obstetric Anesthesia, underscores that large-scale U.S.-based research is essential to confirm its clinical impact in maternity settings.

Adopting VET could reduce maternal deaths and improve precision in transfusion practices, preventing unnecessary use of costly whole blood products. Its potential extends beyond survival benefits, with implications for reducing health disparities, as Black women and women in rural areas face higher maternal mortality rates. Researchers recommend multicenter randomized trials and standardized protocols to guide adoption, ensuring VET is implemented effectively in obstetric care.

“Because it is a point-of-care test that can be done at a patient’s bedside, it provides fast and detailed results within minutes, helping physicians make treatment decisions in real time,” said Carla Janzen, MD, PhD, first author of the publication.

Related Links:
Keck School of Medicine of USC


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Analyzer
respons® UDS100
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.